Giovanni Solimeno: When the Common Femoral Artery Wall is Diseased, Closure is Not a Step
Giovanni Solimeno, Vascular and Endovascular Surgeon at Pineta Grande Hospital, shared a post on LinkedIn:
“When the Common Femoral Artery wall is diseased, closure is not a step — it’s a part of the endovascular access strategy.
We all love fast hemostasis.
But there’s one scenario where a ‘standard’ closure can become a trap:
a patent, non-critical CFA… with a truly diseased wall.
Here’s the mechanism (simple, but easy to underestimate):
If you deploy a closure system that relies on proper wall apposition, and the device lands on a plaque, tension can be imperfect so the intraluminal component may end up malapposed.
And then two things can happen:
- Incomplete hemostasis is usually manageable with compression.
- The real problem: an intraluminal foreign body and disturbed flow can increase the risk of acute thrombosis/occlusion in a vessel you absolutely don’t want to lose.
So my practical rule is simple, but non-negotiable:
- US-guided puncture – always. Find the healthiest CFA segment.
- If the wall is hostile and I can’t guarantee a safe landing zone, I’m happy to compress, or I choose a strategy that doesn’t leave anything intraluminal.
- Closure is not ‘after the case’. It’s part of the case.
How do you handle closure in a calcified / diseased CFA? Any personal red flags?”

Stay updated with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering